The US Pharmacopeia highlights risks of Red Sea trade disruptions, impacting US drug supplies, with 73% of flumazenil APIs ...

Acumetis, formed by merging five firms, offers strategic support for life sciences, with 350 experts across 50+ markets and ...

Plasmid DNA is critical for cell and gene therapies, but scaling high-purity production remains challenging as CDMO partners ...

Middle East conflict disrupts pharma supply chains, raising costs and risking shortages of key medicines globally.

This webinar explores an integrated approach to mAb development that embeds manufacturability, scalability, lifecycle ...

Regeneron and Telix join forces in a 50/50 collaboration to develop and commercialize next-gen radiopharmaceuticals, ...

Aragen unveils ChemiSHE, a woman-led lab in Hyderabad, aiming to boost gender diversity with 800+ hires in science and ...

RT-MALS can provide instantaneous measurements of adenovirus particle size and titer during downstream and fill–finish ...

Emerging pathways can help cell and gene therapies become commercially viable for intractable diseases, even with uneven scalability and consistency.

Despite persistent cost concerns, continued innovation is reinforcing the chromatography resin market’s long-term growth.

Neuland Laboratories appoints Saharsh Davuluri as CEO to lead its $30m peptide facility expansion, targeting growth in ...

NIIMBL’s 2025 National Meeting emphasized the need for system interoperability through standardization of means for data ...